Monomeric CXCL12 outperforms its dimeric and wild type variants in the promotion of human endothelial progenitor cells’ function
- 1 June 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 488 (2) , 303-310
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81522015, 81371305, 81471178)
- K. C. Wong Education Foundation (GYY)
- Science and Technology Commission of Shanghai Municipality (13ZR1422600)
This publication has 28 references indexed in Scilit:
- Postacute Stromal Cell–Derived Factor-1α Expression Promotes Neurovascular Recovery in Ischemic MiceStroke, 2014
- CXCL12 Signaling in the Development of the Nervous SystemJournal of Neuroimmune Pharmacology, 2012
- Concise Review: Circulating Endothelial Progenitor Cells for Vascular MedicineStem Cells, 2011
- Endothelial progenitor cell transplantation improves long‐term stroke outcome in miceAnnals of Neurology, 2010
- Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitusJournal of Cellular and Molecular Medicine, 2010
- Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12Science Signaling, 2008
- Ex Vivo Priming of Endothelial Progenitor Cells With SDF-1 Before Transplantation Could Increase Their Proangiogenic PotentialArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Regulation of endothelial progenitor cell homing after arterial injuryThrombosis and Haemostasis, 2007
- Solution Studies of Recombinant Human Stromal-Cell-Derived Factor-1Protein Expression and Purification, 2001
- Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularizationJournal of Clinical Investigation, 2000